APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latanoprost API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Latanoprost API Industry Growth and Trends Forecast to 2032

31 December 2025111 pages

Choose your research edition.

Industry ResearchLatanoprost API Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Latanoprost API Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Latanoprost API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latanoprost API Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Latanoprost API Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Latanoprost API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Latanoprost API include Sanofi, Guangzhou Tosun Pharmaceutical, Ausun Pharm, Summit Pharmaceuticals, NEWCHEM, Gentec Pharmaceutical Group, Fleming Laboratories, Euroapi and Dr Pradeep Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Latanoprost API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Latanoprost API market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Latanoprost API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Latanoprost API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Latanoprost API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Latanoprost API Market by Company

Sanofi

Guangzhou Tosun Pharmaceutical

Ausun Pharm

Summit Pharmaceuticals

NEWCHEM

Gentec Pharmaceutical Group

Fleming Laboratories

Euroapi

Dr Pradeep Reddy’s Laboratories

DongWha Pharm

DEAFARMA

Chemo

Century Pharmaceuticals

Cayman Pharma

Berr Chemical

Aspen Biopharma

Latanoprost API Segment by Type

Liquid

Powder

Latanoprost API Segment by Application

Glaucoma

High Eye Pressure

Others

Latanoprost API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latanoprost API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Latanoprost API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Latanoprost API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liquid Table 2. Major Company of Powder Table 3. Global Latanoprost API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Latanoprost API Sales by Type (2021-2026) & (K Units) Table 5. Global Latanoprost API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Latanoprost API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Latanoprost API Sales Market Share in Value by Type (2021-2026) Table 8. Global Latanoprost API Price by Type (2021-2026) & (US$/Unit) Table 9. Global Latanoprost API Sales by Type (2027-2032) & (K Units) Table 10. Global Latanoprost API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Latanoprost API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Latanoprost API Sales Market Share in Value by Type (2027-2032) Table 13. Global Latanoprost API Price by Type (2027-2032) & (US$/Unit) Table 14. North America Latanoprost API Sales by Type (2021-2026) & (K Units) Table 15. North America Latanoprost API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Latanoprost API Sales by Type (2021-2026) & (K Units) Table 17. Europe Latanoprost API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Latanoprost API Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Latanoprost API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Latanoprost API Sales by Type (2021-2026) & (K Units) Table 21. Latin America Latanoprost API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Latanoprost API Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Latanoprost API Sales by Type (2021-2026) & (US$ Million) Table 24. Latanoprost API Industry Trends Table 25. Latanoprost API Industry Drivers Table 26. Latanoprost API Industry Opportunities and Challenges Table 27. Latanoprost API Industry Restraints Table 28. Global Latanoprost API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Latanoprost API Revenue Market Share by Company (2021-2026) Table 30. Global Latanoprost API Sales by Company (2021-2026) & (K Units) Table 31. Global Latanoprost API Sales Share by Company (2021-2026) Table 32. Global Latanoprost API Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Latanoprost API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Latanoprost API Major Company Production Sites and Headquarters Table 35. Global Latanoprost API Company, Product Type & Application Table 36. Global Latanoprost API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Latanoprost API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Latanoprost API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Latanoprost API Sales by Region (2021-2026) & (K Units) Table 41. Global Latanoprost API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Latanoprost API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Latanoprost API Sales Market Share in Value by Region (2021-2026) Table 44. Global Latanoprost API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Latanoprost API Sales by Region (2027-2032) & (K Units) Table 46. Global Latanoprost API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Latanoprost API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Latanoprost API Sales Market Share in Value by Region (2027-2032) Table 49. Global Latanoprost API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Latanoprost API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Latanoprost API Sales by Application (2021-2026) & (K Units) Table 52. Global Latanoprost API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Latanoprost API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Latanoprost API Sales Market Share in Value by Application (2021-2026) Table 55. Global Latanoprost API Price by Application (2021-2026) & (US$/Unit) Table 56. Global Latanoprost API Sales by Application (2027-2032) & (K Units) Table 57. Global Latanoprost API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Latanoprost API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Latanoprost API Sales Market Share in Value by Application (2027-2032) Table 60. Global Latanoprost API Price by Application (2027-2032) & (US$/Unit) Table 61. North America Latanoprost API Sales by Application (2021-2026) & (K Units) Table 62. North America Latanoprost API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Latanoprost API Sales by Application (2021-2026) & (K Units) Table 64. Europe Latanoprost API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Latanoprost API Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Latanoprost API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Latanoprost API Sales by Application (2021-2026) & (K Units) Table 68. Latin America Latanoprost API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Latanoprost API Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Latanoprost API Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Latanoprost API Product Portfolio Table 75. Sanofi Recent Development Table 76. Guangzhou Tosun Pharmaceutical Company Information Table 77. Guangzhou Tosun Pharmaceutical Business Overview Table 78. Guangzhou Tosun Pharmaceutical Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guangzhou Tosun Pharmaceutical Latanoprost API Product Portfolio Table 80. Guangzhou Tosun Pharmaceutical Recent Development Table 81. Ausun Pharm Company Information Table 82. Ausun Pharm Business Overview Table 83. Ausun Pharm Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Ausun Pharm Latanoprost API Product Portfolio Table 85. Ausun Pharm Recent Development Table 86. Summit Pharmaceuticals Company Information Table 87. Summit Pharmaceuticals Business Overview Table 88. Summit Pharmaceuticals Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Summit Pharmaceuticals Latanoprost API Product Portfolio Table 90. Summit Pharmaceuticals Recent Development Table 91. NEWCHEM Company Information Table 92. NEWCHEM Business Overview Table 93. NEWCHEM Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. NEWCHEM Latanoprost API Product Portfolio Table 95. NEWCHEM Recent Development Table 96. Gentec Pharmaceutical Group Company Information Table 97. Gentec Pharmaceutical Group Business Overview Table 98. Gentec Pharmaceutical Group Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Gentec Pharmaceutical Group Latanoprost API Product Portfolio Table 100. Gentec Pharmaceutical Group Recent Development Table 101. Fleming Laboratories Company Information Table 102. Fleming Laboratories Business Overview Table 103. Fleming Laboratories Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Fleming Laboratories Latanoprost API Product Portfolio Table 105. Fleming Laboratories Recent Development Table 106. Euroapi Company Information Table 107. Euroapi Business Overview Table 108. Euroapi Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Euroapi Latanoprost API Product Portfolio Table 110. Euroapi Recent Development Table 111. Dr Pradeep Reddy’s Laboratories Company Information Table 112. Dr Pradeep Reddy’s Laboratories Business Overview Table 113. Dr Pradeep Reddy’s Laboratories Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Dr Pradeep Reddy’s Laboratories Latanoprost API Product Portfolio Table 115. Dr Pradeep Reddy’s Laboratories Recent Development Table 116. DongWha Pharm Company Information Table 117. DongWha Pharm Business Overview Table 118. DongWha Pharm Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. DongWha Pharm Latanoprost API Product Portfolio Table 120. DongWha Pharm Recent Development Table 121. DEAFARMA Company Information Table 122. DEAFARMA Business Overview Table 123. DEAFARMA Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. DEAFARMA Latanoprost API Product Portfolio Table 125. DEAFARMA Recent Development Table 126. Chemo Company Information Table 127. Chemo Business Overview Table 128. Chemo Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chemo Latanoprost API Product Portfolio Table 130. Chemo Recent Development Table 131. Century Pharmaceuticals Company Information Table 132. Century Pharmaceuticals Business Overview Table 133. Century Pharmaceuticals Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Century Pharmaceuticals Latanoprost API Product Portfolio Table 135. Century Pharmaceuticals Recent Development Table 136. Cayman Pharma Company Information Table 137. Cayman Pharma Business Overview Table 138. Cayman Pharma Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Cayman Pharma Latanoprost API Product Portfolio Table 140. Cayman Pharma Recent Development Table 141. Berr Chemical Company Information Table 142. Berr Chemical Business Overview Table 143. Berr Chemical Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Berr Chemical Latanoprost API Product Portfolio Table 145. Berr Chemical Recent Development Table 146. Aspen Biopharma Company Information Table 147. Aspen Biopharma Business Overview Table 148. Aspen Biopharma Latanoprost API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Aspen Biopharma Latanoprost API Product Portfolio Table 150. Aspen Biopharma Recent Development Table 151. North America Latanoprost API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. North America Latanoprost API Sales by Country (2021-2026) & (K Units) Table 153. North America Latanoprost API Sales Market Share by Country (2021-2026) Table 154. North America Latanoprost API Sales Forecast by Country (2027-2032) & (K Units) Table 155. North America Latanoprost API Sales Market Share Forecast by Country (2027-2032) Table 156. North America Latanoprost API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Latanoprost API Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Latanoprost API Market Share by Country (2021-2026) Table 159. North America Latanoprost API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Latanoprost API Market Share Forecast by Country (2027-2032) Table 161. Europe Latanoprost API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Europe Latanoprost API Sales by Country (2021-2026) & (K Units) Table 163. Europe Latanoprost API Sales Market Share by Country (2021-2026) Table 164. Europe Latanoprost API Sales Forecast by Country (2027-2032) & (K Units) Table 165. Europe Latanoprost API Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Latanoprost API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Latanoprost API Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Latanoprost API Market Share by Country (2021-2026) Table 169. Europe Latanoprost API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Latanoprost API Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Latanoprost API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Latanoprost API Sales by Country (2021-2026) & (K Units) Table 173. Asia-Pacific Latanoprost API Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Latanoprost API Sales Forecast by Country (2027-2032) & (K Units) Table 175. Asia-Pacific Latanoprost API Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Latanoprost API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Latanoprost API Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Latanoprost API Market Share by Country (2021-2026) Table 179. Asia-Pacific Latanoprost API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Latanoprost API Market Share Forecast by Country (2027-2032) Table 181. Latin America Latanoprost API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Latin America Latanoprost API Sales by Country (2021-2026) & (K Units) Table 183. Latin America Latanoprost API Sales Market Share by Country (2021-2026) Table 184. Latin America Latanoprost API Sales Forecast by Country (2027-2032) & (K Units) Table 185. Latin America Latanoprost API Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Latanoprost API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Latanoprost API Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Latanoprost API Market Share by Country (2021-2026) Table 189. Latin America Latanoprost API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Latanoprost API Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Latanoprost API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Latanoprost API Sales by Country (2021-2026) & (K Units) Table 193. Middle East and Africa Latanoprost API Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Latanoprost API Sales Forecast by Country (2027-2032) & (K Units) Table 195. Middle East and Africa Latanoprost API Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Latanoprost API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Latanoprost API Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Latanoprost API Market Share by Country (2021-2026) Table 199. Middle East and Africa Latanoprost API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Latanoprost API Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Latanoprost API Distributors List Table 204. Latanoprost API Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Latanoprost API Image Figure 2. Global Latanoprost API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latanoprost API Market Size (2021-2032) & (US$ Million) Figure 4. Global Latanoprost API Sales (2021-2032) & (K Units) Figure 5. Liquid Image Figure 6. Global Liquid Sales YoY Growth (2021-2032) & (K Units) Figure 7. Powder Image Figure 8. Global Powder Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Latanoprost API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Latanoprost API Market Share by Type 2025 VS 2032 Figure 11. North America Latanoprost API Sales Market Share in Volume by Type in 2025 Figure 12. North America Latanoprost API Sales Market Share in Value by Type in 2025 Figure 13. Europe Latanoprost API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Latanoprost API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Latanoprost API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Latanoprost API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Latanoprost API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Latanoprost API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Latanoprost API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Latanoprost API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Latanoprost API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Glaucoma Image Figure 24. Global Glaucoma Sales YoY Growth (2021-2032) & (K Units) Figure 25. High Eye Pressure Image Figure 26. Global High Eye Pressure Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Latanoprost API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Latanoprost API Market Share by Application 2025 VS 2032 Figure 31. North America Latanoprost API Sales Market Share in Volume by Application in 2025 Figure 32. North America Latanoprost API Sales Market Share in Value by Application in 2025 Figure 33. Europe Latanoprost API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Latanoprost API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Latanoprost API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Latanoprost API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Latanoprost API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Latanoprost API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Latanoprost API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Latanoprost API Sales Market Share in Value by Application in 2025 Figure 41. North America Latanoprost API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Latanoprost API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Latanoprost API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Latanoprost API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Latanoprost API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Latanoprost API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Latanoprost API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Latanoprost API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Latanoprost API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Latanoprost API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Latanoprost API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Latanoprost API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Latanoprost API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Latanoprost API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Latanoprost API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latanoprost API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Latanoprost API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Glaucoma
  • High Eye Pressure
  • Others
Companies covered
  • Sanofi
  • Guangzhou Tosun Pharmaceutical
  • Ausun Pharm
  • Summit Pharmaceuticals
  • NEWCHEM
  • Gentec Pharmaceutical Group
  • Fleming Laboratories
  • Euroapi
  • Dr Pradeep Reddy’s Laboratories
  • DongWha Pharm
  • DEAFARMA
  • Chemo
  • Century Pharmaceuticals
  • Cayman Pharma
  • Berr Chemical
  • Aspen Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Latanoprost API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Latanoprost API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Latanoprost API Market by Type
  6. 1.3.1 Liquid
  7. 1.3.2 Powder
  8. 1.4 Global Latanoprost API Market Size by Type
  9. 1.4.1 Global Latanoprost API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Latanoprost API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Latanoprost API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Latanoprost API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Latanoprost API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Latanoprost API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Latanoprost API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Latanoprost API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Latanoprost API Industry Trends
  2. 2.2 Latanoprost API Industry Drivers
  3. 2.3 Latanoprost API Industry Opportunities and Challenges
  4. 2.4 Latanoprost API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Latanoprost API Revenue (2021-2026)
  2. 3.2 Global Top Players by Latanoprost API Sales (2021-2026)
  3. 3.3 Global Top Players by Latanoprost API Price (2021-2026)
  4. 3.4 Global Latanoprost API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Latanoprost API Major Company Production Sites & Headquarters
  6. 3.6 Global Latanoprost API Company, Product Type & Application
  7. 3.7 Global Latanoprost API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Latanoprost API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Latanoprost API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Latanoprost API Tier 1, Tier 2, and Tier 3
4 Latanoprost API Regional Status and Outlook
  1. 4.1 Global Latanoprost API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Latanoprost API Historic Market Size by Region
  3. 4.2.1 Global Latanoprost API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Latanoprost API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Latanoprost API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Latanoprost API Forecasted Market Size by Region
  7. 4.3.1 Global Latanoprost API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Latanoprost API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Latanoprost API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Latanoprost API by Application
  1. 5.1 Latanoprost API Market by Application
  2. 5.1.1 Glaucoma
  3. 5.1.2 High Eye Pressure
  4. 5.1.3 Others
  5. 5.2 Global Latanoprost API Market Size by Application
  6. 5.2.1 Global Latanoprost API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Latanoprost API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Latanoprost API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Latanoprost API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Latanoprost API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Latanoprost API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Latanoprost API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Latanoprost API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Latanoprost API Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Guangzhou Tosun Pharmaceutical
  8. 6.2.1 Guangzhou Tosun Pharmaceutical Company Information
  9. 6.2.2 Guangzhou Tosun Pharmaceutical Business Overview
  10. 6.2.3 Guangzhou Tosun Pharmaceutical Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guangzhou Tosun Pharmaceutical Latanoprost API Product Portfolio
  12. 6.2.5 Guangzhou Tosun Pharmaceutical Recent Developments
  13. 6.3 Ausun Pharm
  14. 6.3.1 Ausun Pharm Company Information
  15. 6.3.2 Ausun Pharm Business Overview
  16. 6.3.3 Ausun Pharm Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ausun Pharm Latanoprost API Product Portfolio
  18. 6.3.5 Ausun Pharm Recent Developments
  19. 6.4 Summit Pharmaceuticals
  20. 6.4.1 Summit Pharmaceuticals Company Information
  21. 6.4.2 Summit Pharmaceuticals Business Overview
  22. 6.4.3 Summit Pharmaceuticals Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Summit Pharmaceuticals Latanoprost API Product Portfolio
  24. 6.4.5 Summit Pharmaceuticals Recent Developments
  25. 6.5 NEWCHEM
  26. 6.5.1 NEWCHEM Company Information
  27. 6.5.2 NEWCHEM Business Overview
  28. 6.5.3 NEWCHEM Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NEWCHEM Latanoprost API Product Portfolio
  30. 6.5.5 NEWCHEM Recent Developments
  31. 6.6 Gentec Pharmaceutical Group
  32. 6.6.1 Gentec Pharmaceutical Group Company Information
  33. 6.6.2 Gentec Pharmaceutical Group Business Overview
  34. 6.6.3 Gentec Pharmaceutical Group Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gentec Pharmaceutical Group Latanoprost API Product Portfolio
  36. 6.6.5 Gentec Pharmaceutical Group Recent Developments
  37. 6.7 Fleming Laboratories
  38. 6.7.1 Fleming Laboratories Company Information
  39. 6.7.2 Fleming Laboratories Business Overview
  40. 6.7.3 Fleming Laboratories Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Fleming Laboratories Latanoprost API Product Portfolio
  42. 6.7.5 Fleming Laboratories Recent Developments
  43. 6.8 Euroapi
  44. 6.8.1 Euroapi Company Information
  45. 6.8.2 Euroapi Business Overview
  46. 6.8.3 Euroapi Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Euroapi Latanoprost API Product Portfolio
  48. 6.8.5 Euroapi Recent Developments
  49. 6.9 Dr Pradeep Reddy’s Laboratories
  50. 6.9.1 Dr Pradeep Reddy’s Laboratories Company Information
  51. 6.9.2 Dr Pradeep Reddy’s Laboratories Business Overview
  52. 6.9.3 Dr Pradeep Reddy’s Laboratories Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr Pradeep Reddy’s Laboratories Latanoprost API Product Portfolio
  54. 6.9.5 Dr Pradeep Reddy’s Laboratories Recent Developments
  55. 6.10 DongWha Pharm
  56. 6.10.1 DongWha Pharm Company Information
  57. 6.10.2 DongWha Pharm Business Overview
  58. 6.10.3 DongWha Pharm Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 DongWha Pharm Latanoprost API Product Portfolio
  60. 6.10.5 DongWha Pharm Recent Developments
  61. 6.11 DEAFARMA
  62. 6.11.1 DEAFARMA Company Information
  63. 6.11.2 DEAFARMA Business Overview
  64. 6.11.3 DEAFARMA Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 DEAFARMA Latanoprost API Product Portfolio
  66. 6.11.5 DEAFARMA Recent Developments
  67. 6.12 Chemo
  68. 6.12.1 Chemo Company Information
  69. 6.12.2 Chemo Business Overview
  70. 6.12.3 Chemo Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chemo Latanoprost API Product Portfolio
  72. 6.12.5 Chemo Recent Developments
  73. 6.13 Century Pharmaceuticals
  74. 6.13.1 Century Pharmaceuticals Company Information
  75. 6.13.2 Century Pharmaceuticals Business Overview
  76. 6.13.3 Century Pharmaceuticals Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Century Pharmaceuticals Latanoprost API Product Portfolio
  78. 6.13.5 Century Pharmaceuticals Recent Developments
  79. 6.14 Cayman Pharma
  80. 6.14.1 Cayman Pharma Company Information
  81. 6.14.2 Cayman Pharma Business Overview
  82. 6.14.3 Cayman Pharma Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cayman Pharma Latanoprost API Product Portfolio
  84. 6.14.5 Cayman Pharma Recent Developments
  85. 6.15 Berr Chemical
  86. 6.15.1 Berr Chemical Company Information
  87. 6.15.2 Berr Chemical Business Overview
  88. 6.15.3 Berr Chemical Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Berr Chemical Latanoprost API Product Portfolio
  90. 6.15.5 Berr Chemical Recent Developments
  91. 6.16 Aspen Biopharma
  92. 6.16.1 Aspen Biopharma Company Information
  93. 6.16.2 Aspen Biopharma Business Overview
  94. 6.16.3 Aspen Biopharma Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aspen Biopharma Latanoprost API Product Portfolio
  96. 6.16.5 Aspen Biopharma Recent Developments
7 North America by Country
  1. 7.1 North America Latanoprost API Sales by Country
  2. 7.1.1 North America Latanoprost API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Latanoprost API Sales by Country (2021-2026)
  4. 7.1.3 North America Latanoprost API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Latanoprost API Market Size by Country
  6. 7.2.1 North America Latanoprost API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Latanoprost API Market Size by Country (2021-2026)
  8. 7.2.3 North America Latanoprost API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Latanoprost API Sales by Country
  2. 8.1.1 Europe Latanoprost API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Latanoprost API Sales by Country (2021-2026)
  4. 8.1.3 Europe Latanoprost API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Latanoprost API Market Size by Country
  6. 8.2.1 Europe Latanoprost API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Latanoprost API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Latanoprost API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Latanoprost API Sales by Country
  2. 9.1.1 Asia-Pacific Latanoprost API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Latanoprost API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Latanoprost API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Latanoprost API Market Size by Country
  6. 9.2.1 Asia-Pacific Latanoprost API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Latanoprost API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Latanoprost API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Latanoprost API Sales by Country
  2. 10.1.1 South America Latanoprost API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Latanoprost API Sales by Country (2021-2026)
  4. 10.1.3 South America Latanoprost API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Latanoprost API Market Size by Country
  6. 10.2.1 South America Latanoprost API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Latanoprost API Market Size by Country (2021-2026)
  8. 10.2.3 South America Latanoprost API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Latanoprost API Sales by Country
  2. 11.1.1 Middle East and Africa Latanoprost API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Latanoprost API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Latanoprost API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Latanoprost API Market Size by Country
  6. 11.2.1 Middle East and Africa Latanoprost API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Latanoprost API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Latanoprost API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Latanoprost API Value Chain Analysis
  2. 12.1.1 Latanoprost API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Latanoprost API Production Mode & Process
  7. 12.2 Latanoprost API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Latanoprost API Distributors
  10. 12.2.3 Latanoprost API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst